Development of new p38 protein inhibitors with therapeutic potential for some heart diseases

by IRB Barcelona - Instituto de Investigación Biomédica

A research team from IRB Barcelona and the biotech Nostrum Biodiscovery has developed a new type of inhibitor that blocks only some of the functions of the p38 protein. The alternative pathway that th...

Read more

Launch of Nostrum BioDiscovery, a spin-off that applies supercomputing to speed up drug discovery

by IRB Barcelona - Instituto de Investigación Biomédica

Nostrum BioDiscovery has come about from the combined efforts of IRB Barcelona and the BSC-CNS—two research centres of excellence in Barcelona—with the participation of the University of Barcelona...

Read more
Subscribe to Directory
Write an Article

Recent News

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

New strategy to facilitate muscle regen...

by Universitat de Barcelona

This is the first study to provide scientific evidence for faster and ...

Photos Stream